Chromosomal changes in prostate cancer: A fluorescence in situ hybridization study

Clinical Genetics

Volumn 68, Issue 1, 2005, Pages 40-47

  Das, Kakoli ^a   Lau, W ^a   Sivaswaren, C R ^a   Tan, P H ^a   Fook Chong, S M C ^a   Tien, S L ^a   Cheng, C ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Chromosomal aberrations; Fluorescence in situ hybridization; Paraffin sections; Prostate cancer; Tissue microarray

Indexed keywords

ADULT; ADVANCED CANCER; AGED; AGING; ANEUPLOIDY; ARTICLE; CANCER INCIDENCE; CHROMOSOME 11Q; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CYTOGENETICS; DISOMY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SINGAPORE;

ADULT; AGED; AGED, 80 AND OVER; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOME ABERRATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; JAPAN; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SINGAPORE; SWEDEN;

EID: 20944439777     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2005.00452.x     Document Type: Article

References (38)

1. Chia KS, Seow A, Lee HP, Shanmugaratnam K. Cancer incidence in Singapore 1998-2002. Singapore Cancer Registry Report No. 6, 2004: 128-129.
2. Shen AC, Shen MM. Molecular genetics of prostate cancer. Genes Dev 2000: 14: 2410-2434.
3. Carter BS, Beaty TH, Steinberg GD et al. Mendelian inheritance of early onset familial prostate cancer. Proc Natl Acad Sci USA 1992: 89: 3367-3371.
4. Carter BS, Bova GS, Steinberg GD et al. Hereditary prostate cancer: Clinical and epidemiologic features. J Urol 1993: 150: 797-802.
5. Macoska JA, Trybus TM, Sakr WA et al. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 1994: 54 (14): 3824-3830.
6. Matsuyama H, Pan Y, Skoog L et al. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Am J Pathol 1994: 145 (3): 624-630.
7. Matsuyama H, Pan Y, Oba K et al. Deletions on chromosome Sp22 may predict disease progression as well as pathological staging in prostate cancer. Clin Cancer Res 2001: 7: 3139-3143.
8. Oba K, Matsuyama H, Yoshihiro S et al. Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer. Cancer Genet Cytogenet 2001: 124 (1): 20-26.
9. 0 prostate cancer are potential markers for cancer progression. Mod Pathol 2002: 15 (1): 35-44.
10. Takahashi S, Qian J, Brown JA et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization. Cancer Res 1994: 54: 3574-3579.
11. Sato K, Qian J, Slezak JM et al. Clinical significance of alterations of chromosome 8 in high-grade, advanced, non-metastatic prostate carcinoma. J Natl Cancer Inst 1999: 91 (18): 1574-1580.
12. Cui J, Deubler DA, Rohr LR et al. Chromosome 7 abnormalities in prostate cancer detected by dual color FISH. Cancer Genet Cytogenet 1998: 107 (1): 51-60.
13. Celep F, Karaguzel A, Ozgur GK, Yildiz K. Detection of chromosomal aberrations in prostate cancer by fluorescence in situ hybridization (FISH). Eur Urol 2003: 44: 666-671.
14. Bandyk MG, Zhao L, Troncoso P et al. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes Cancer 1994: 9: 19-27.
15. Matsuura H, Shiraishi T, Yatani R, Kawamura J. Interphase cytogenetics of prostate cancer: fluorescence in situ hybridisation (FISH) analysis of Japanese cases. Br J Cancer 1996: 74 (11): 1699-1704.
16. Hughes JH, Cohen MJB, Robinson RA. p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma. Mod Pathol 1995: 8: 462-466.
17. Theodorescu D, Broder SR, Boyd JC et al. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate. J Urol 1997: 158: 131-137.
18. Brooks JD, Bova GS, Ewing CM et al. An uncertain role for p53 gene alterations in human prostate cancers. Cancer Res 1996: 56: 3814-3822.
19. Watnabe M, Ushijima T, Kakiuchi H et al. p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries. Jpn J Cancer Res 1994: 48: 2887-2889.
20. Sobin LH, Whittkind CH. UICC: TNM classification of malignant tumours. New York: Wiley, 1997: 170-173.
21. Bubendorf L, Kononen J, Koivisto P et al. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 1999: 59 (4): 803-806.
22. Brown JA, Alcaraz A, Takahashi S et al. Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 1994: 152: 1157-1162.
23. Matsuyama H, Bergerheim USR, Nilsson I et al. Nonrandom numerical aberrations of chromosomes 7, 9 and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 1994: 77: 118-124.
24. Qian J, Bostwick DG, Takahashi S et al. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol 1996: 149 (4): 1193-1199.
25. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997: 57 (3): 524-531.
26. Mark HF, Samy M, Santoro K et al. Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer. Exp Mol Pathol 2000: 68 (1): 65-69.
27. Tsuchiya N, Slezak JM, Lieber MM et al. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer 2002: 34: 363-371.
28. Virgin JB, Hurley PM, Nahhas FA et al. Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line. Prostate 1999: 41: 49-57.
29. Miyoshi Y, Uemura H, Fujinami K et al. Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients. Prostate 2000: 43: 225-232.
30. Alcaraz A, Takahashi S, Brown JA et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 1994: 54 (15): 3998-4002.
31. Barranco MA, Alcaraz A, Corral JM et al. Numeric alterations in chromosomes 7 and 8 detected by fluorescent in situ hybridization correlate with high-grade localized prostate cancer. Eur Urol 1998: 34 (5): 419-425.
32. Zitzelsberger H, Szucs S, Weier HU et al. Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J Pathol 1994: 172 (4): 325-335.
33. Micale MA, Sanford JS, Powell IJ, Sakr WA, Wolman SR. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis. Cancer Genet Cytogenet 1993: 69 (1): 7-12.
34. Macoska JA, Micale MA, Sakr WA et al. Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes Cancer 1993: 8: 88.
35. Brothman AR, Patel AM, Peehl DM, Schellhammer PF. Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 1992: 62 (2): 180-185.
36. Brothman AR. Cytogenetic studies in prostate cancer: are we making progress? Cancer Genet Cytogenet 1997: 95 (1): 116-121.
37. Jones E, Zhu XL, Rohr LR et al. Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chromosomes Cancer 1994: 11 (3): 163-170.
38. Karan D, Lin MF, Johansson SL, Batra SK. Current status of the molecular genetics of human prostatic adenocarcinomas. Int J Cancer 2003: 103: 285-293.